Bicara Therapeutics Nasdaq Debut: Biocon founder and Chairperson Kiran Mazumdar-Shaw expressed her pride and joy on Wednesday as her niece, Claire Mazumdar, made a significant achievement with the ...

Amidst rising complaints, Biocon founder Kiran Mazumdar Shaw has proposed an alternative approach for road repairs to address the city’s notorious pothole problem. The 71-year-old business icon ...

At least the ones we are working on, I don’t think they can get to clinics before 9 months,” Kiran Mazumdar Shaw, Founder and Executive Chairperson, Biocon told Business Insider. Vaccine ...

Brokerages have turned bullish over Biocon's growth prospects after the US FDA clearance of the drugmaker's Malaysia unit ...

The biggest percentage gainer was 67-year old Kiran Mazumdar-Shaw, Biocon founder and the second richest woman in India. While Biocon has joined the race to discover the vaccine, Shaw was not ...

The drug was developed by a gene and cell therapy startup, supported by Biocon founder Kiran Mazumdar Shaw and oncologist and author Dr Siddhartha Mukherjee. Amit Mookim, CEO of Immuneel Therapeutics, ...

Biocon Ltd shares rose 4.7% after HSBC upgraded its rating to "buy" and raised the target price to Rs 430. The upgrade ...

Biocon shares increased by 4.5% after the US FDA classified its Malaysian insulin facilities as Voluntary Action Indicated. This followed an inspection conducted in September 2024. BofA maintained its ...